Literature DB >> 30074405

Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis.

Hong-Hao Sun1,2, Feng Tian3.   

Abstract

Background The risk of cardiovascular disease occurrence and death in inflammatory bowel disease patients is still unclear. Design Meta-analysis. Methods Pertinent studies were identified by searching articles in PubMed and Web of Knowledge to December 2017 and reviewing the reference lists of the retrieved articles. We used the fixed-effect model to pool the study-specific estimates when there was no indication of heterogeneity; otherwise, the random-effect model was used. Results A total of 27 articles was included, of which 11 studies reported the risk of cardiovascular disease incidence and 16 studies reported the risk of cardiovascular disease death. The pooled relative risks were 1.25 (95% confidence interval (CI): 1.08, 1.44), 1.17 (95% CI: 1.07, 1.27) and 1.12 (95% CI: 1.05, 1.21) for cerebrovascular disease, coronary heart disease and myocardial infarction, respectively. In particular, the pooled relative risk was much higher in females. The pooled standardized mortality ratios were 1.01 (95% CI: 0.90, 1.14) for Crohn's disease patients and 0.93 (95% CI: 0.86, 1.01) for ulcerative colitis patients with low heterogeneity across studies. No publication bias was detected. Conclusions There was a positive association between inflammatory bowel disease and higher risk of cardiovascular disease incidence, particularly in females. Such an association was not observed for cardiovascular disease mortality.

Entities:  

Keywords:  Crohn's disease; Inflammatory bowel disease; cardiovascular disease; meta-analysis; ulcerative colitis

Mesh:

Year:  2018        PMID: 30074405     DOI: 10.1177/2047487318792952

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  15 in total

1.  International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

Authors:  Pablo A Olivera; Stephane Zuily; Paulo G Kotze; Veronique Regnault; Sameer Al Awadhi; Peter Bossuyt; Richard B Gearry; Subrata Ghosh; Taku Kobayashi; Patrick Lacolley; Edouard Louis; Fernando Magro; Siew C Ng; Alfredo Papa; Tim Raine; Fabio V Teixeira; David T Rubin; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

Review 2.  Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies.

Authors:  Diana-Maria Bunu; Cristian-Eugen Timofte; Manuela Ciocoiu; Mariana Floria; Claudia-Cristina Tarniceriu; Oana-Bogdana Barboi; Daniela-Maria Tanase
Journal:  Gastroenterol Res Pract       Date:  2019-01-13       Impact factor: 2.260

3.  Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study.

Authors:  Jorrit L Opstelten; Ilonca Vaartjes; Michiel L Bots; Bas Oldenburg
Journal:  Inflamm Bowel Dis       Date:  2019-09-18       Impact factor: 5.325

4.  Arterial Stiffness in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis.

Authors:  Qiongqiong Lu; Rui Shi; Tangyou Mao; Zhibin Wang; Zhongmei Sun; Xiang Tan; Yi Wang; Junxiang Li
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.555

5.  An Investigation into the Association Between Inflammatory Bowel Disease and Cardiac Arrhythmias: An Examination of the United States National Inpatient Sample Database.

Authors:  Mahmood Mubasher; Tausif Syed; Amir Hanafi; Zhao Yu; Ibrahim Yusuf; Abdullah Sayied Abdullah; Mouhand Fh Mohamed; Richard Alweis; Mohan Rao; Ryan Hoefen; Mohammed I Danjuma
Journal:  Clin Med Insights Cardiol       Date:  2020-10-28

Review 6.  The risk of cardiovascular complications in inflammatory bowel disease.

Authors:  Piotr Czubkowski; Marcin Osiecki; Edyta Szymańska; Jarosław Kierkuś
Journal:  Clin Exp Med       Date:  2020-08-12       Impact factor: 3.984

Review 7.  GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases.

Authors:  Nehal N Mehta; Amit K Dey; Reethika Maddineni; William E Kraus; Kim M Huffman
Journal:  Am J Prev Cardiol       Date:  2020-11-07

8.  Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey.

Authors:  Khurram Nasir; Isaac Acquah; Amit K Dey; Tanushree Agrawal; Syed Zawahir Hassan; Kerri Glassner; Bincy Abraham; Eamonn M M Quigley; Ron Blankstein; Salim S Virani; Michael J Blaha; Javier Valero-Elizondo; Miguel Cainzos-Achirica; Nehal N Mehta
Journal:  Am J Prev Cardiol       Date:  2022-01-17

9.  Risk factors for cardiovascular disease from a population-based screening study in Tianjin, China: a cohort study of 36,215 residents.

Authors:  Yingyi Zhang; Hongliang Cong; Chen Man; Yu Su; Hongxia Sun; Hua Yang; Zhigang Guo
Journal:  Ann Transl Med       Date:  2020-04

10.  Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice.

Authors:  Rabia Agca; Yvo Smulders; Michael Nurmohamed
Journal:  Heart       Date:  2021-03-04       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.